Stress granules, cellular structures essential for stress response, require poly(ADP-ribose) as a multivalent scaffold. Here, the authors show that disrupting poly(ADP-ribose) binding to PARP13 ...

Granules India Ltd share price was up by 2.77% from the previous closing price of ₹568.00. Who are peers of Granules India Ltd? The peers of Granules India Ltd are Sun Pharmaceuticals Industries ...

The company's market valuation stood at Rs 3,541.97 crore. Jan 13, 2025 11:16 Lupin Gets USFDA Approval for Generic Cystic Fibrosis Treatment Lupin receives USFDA approval for its generic version of ...

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 14,045.24 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...